This webinar will provide a background on patient preference methods and conducting patient preference studies. The topics covered will include overviews of (1) what patient preference information (PPI) is and what it is not, (2) a range of stated-preference methods, (3) the core components in the design of a stated-preference study, and (4) the recommended qualities of patient preference studies that are outlined in FDA’s PPI guidance. In addition, the presenters will use an example of a stated preference study to elucidate some of the concepts addressed in the webinar.
This will serve as an introduction for those who may be less familiar with methods for eliciting PPI and those for whom an overview of methods would be valuable prior to the upcoming ISPOR-FDA Summit 2020 on “Using Patient-Preference Information in Medical Device Regulatory Decisions: Benefit-Risk and Beyond.” The Summit will address issues related to the development and use of PPI in multiple decisions faced by FDA and other stakeholders.
All are invited to attend the webinar (including those registered and not registered for the Summit).
After attending this webinar participants will be able to:
- Explain the range of methods that are included among stated-preference methods;
- Discuss the difference between patient-preference information and other types of input;
- Identify the core components in designing and implementing a stated-preference project; and
- Recognize the recommended qualities of patient preference studies considered when determining whether PPI constitutes valid scientific evidence.